← All companies
CGEM annual net income
Cullinan Therapeutics, Inc.
CGEM - CIK 0001789972
Market cap$1.00 B
Rank#2637
SEC filings435
Cullinan Therapeutics, Inc. net income by year
Cullinan Therapeutics, Inc. (CGEM) reported net income of -$219.88M for fiscal year 2025, as filed in its audited annual report with the SEC.
CGEM net income 2020-2025
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$219.88M | -31.2% |
| FY 2024 | -$167.57M | -8.0% |
| FY 2023 | -$155.10M | -239.5% |
| FY 2022 | $111.21M | +269.6% |
| FY 2021 | -$65.57M | -26.6% |
| FY 2020 | -$51.80M | - |
Net Income of similar companies
Frequently asked questions
How much profit does Cullinan Therapeutics, Inc. make?
Cullinan Therapeutics, Inc. (CGEM) reported net income of -$219.88M for fiscal year 2025, as filed in its audited annual report with the SEC.
How has Cullinan Therapeutics, Inc.'s net income changed over time?
Between fiscal 2020 and fiscal 2025, Cullinan Therapeutics, Inc.'s net income declined from -$51.80M to -$219.88M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.